2.4.1.9 Html 143 279 1 false 53 0 false 5 false false R1.htm 101 - Document - Document And Entity Information Sheet http://www.cytocoreinc.com/role/DocumentAndEntityInformation Document And Entity Information true false R2.htm 102 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.cytocoreinc.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS false false R3.htm 103 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.cytocoreinc.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME Sheet http://www.cytocoreinc.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncome CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME false false R5.htm 105 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Parenthetical) Sheet http://www.cytocoreinc.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeParenthetical CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Parenthetical) false false R6.htm 106 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.cytocoreinc.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS false false R7.htm 107 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://www.cytocoreinc.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) false false R8.htm 108 - Disclosure - The Company and Basis of Presentation Sheet http://www.cytocoreinc.com/role/CompanyAndBasisOfPresentation The Company and Basis of Presentation false false R9.htm 109 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.cytocoreinc.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies false false R10.htm 110 - Disclosure - Reverse Merger Sheet http://www.cytocoreinc.com/role/ReverseMerger Reverse Merger false false R11.htm 111 - Disclosure - Inventories Sheet http://www.cytocoreinc.com/role/Inventories Inventories false false R12.htm 112 - Disclosure - Property and Equipment Sheet http://www.cytocoreinc.com/role/PropertyAndEquipment Property and Equipment false false R13.htm 113 - Disclosure - Bank Debt and Lines of Credit Sheet http://www.cytocoreinc.com/role/BankDebtAndLinesOfCredit Bank Debt and Lines of Credit false false R14.htm 114 - Disclosure - Accrued Expenses Sheet http://www.cytocoreinc.com/role/AccruedExpenses Accrued Expenses false false R15.htm 115 - Statement - Stockholders' Equity Sheet http://www.cytocoreinc.com/role/StockholdersEquity Stockholders' Equity false false R16.htm 116 - Disclosure - Leases Sheet http://www.cytocoreinc.com/role/Leases Leases false false R17.htm 117 - Disclosure - Income Taxes Sheet http://www.cytocoreinc.com/role/IncomeTaxes Income Taxes false false R18.htm 118 - Disclosure - Commitments and Contingencies Sheet http://www.cytocoreinc.com/role/CommitmentsAndContingencies Commitments and Contingencies false false R19.htm 119 - Disclosure - Segment Information Sheet http://www.cytocoreinc.com/role/SegmentInformation Segment Information false false R20.htm 120 - Disclosure - Subsequent Event Sheet http://www.cytocoreinc.com/role/SubsequentEvent Subsequent Event false false R21.htm 121 - Statement - Summary of Significant Accounting Policies (Policies) Sheet http://www.cytocoreinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) false false R22.htm 122 - Statement - Summary of Significant Accounting Policies (Tables) Sheet http://www.cytocoreinc.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) false false R23.htm 123 - Disclosure - Reverse Merger (Tables) Sheet http://www.cytocoreinc.com/role/ReverseMergerTables Reverse Merger (Tables) false false R24.htm 124 - Disclosure - Inventories (Tables) Sheet http://www.cytocoreinc.com/role/InventoriesTables Inventories (Tables) false false R25.htm 125 - Disclosure - Property and Equipment (Tables) Sheet http://www.cytocoreinc.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) false false R26.htm 126 - Statement - Bank Debts and Line of Credit (Tables) Sheet http://www.cytocoreinc.com/role/BankDebtsAndLineOfCreditTables Bank Debts and Line of Credit (Tables) false false R27.htm 127 - Disclosure - Accrued Expenses (Tables) Sheet http://www.cytocoreinc.com/role/AccruedExpensesTables Accrued Expenses (Tables) false false R28.htm 128 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.cytocoreinc.com/role/StockholdersEquityTables Stockholders' Equity (Tables) false false R29.htm 129 - Disclosure - Leases (Tables) Sheet http://www.cytocoreinc.com/role/LeasesTables Leases (Tables) false false R30.htm 130 - Statement - Income Taxes (Tables) Sheet http://www.cytocoreinc.com/role/IncomeTaxesTables Income Taxes (Tables) false false R31.htm 131 - Disclosure - Segment Information (Tables) Sheet http://www.cytocoreinc.com/role/SegmentInformationTables Segment Information (Tables) false false R32.htm 132 - Statement - The Company and Basis of Presentation - Additional Information (Detail) Sheet http://www.cytocoreinc.com/role/CompanyAndBasisOfPresentationAdditionalInformationDetail The Company and Basis of Presentation - Additional Information (Detail) false false R33.htm 133 - Statement - Summary of Significant Accounting Policies (Detail) Sheet http://www.cytocoreinc.com/role/SummaryOfSignificantAccountingPoliciesDetail Summary of Significant Accounting Policies (Detail) false false R34.htm 134 - Disclosure - Reverse Merger - (Estimated Purchase Price Allocation) (Detail) Sheet http://www.cytocoreinc.com/role/ReverseMergerEstimatedPurchasePriceAllocationDetail Reverse Merger - (Estimated Purchase Price Allocation) (Detail) false false R35.htm 135 - Disclosure - Reverse Merger - Additional Information (Detail) Sheet http://www.cytocoreinc.com/role/ReverseMergerAdditionalInformationDetail Reverse Merger - Additional Information (Detail) false false R36.htm 136 - Disclosure - Inventories - (Summary of the Components of Inventories) (Detail) Sheet http://www.cytocoreinc.com/role/InventoriesSummaryOfComponentsOfInventoriesDetail Inventories - (Summary of the Components of Inventories) (Detail) false false R37.htm 137 - Disclosure - Property and Equipment (Detail) Sheet http://www.cytocoreinc.com/role/PropertyAndEquipmentDetail Property and Equipment (Detail) false false R38.htm 138 - Disclosure - Bank Debts and Lines of Credit (Detail) Sheet http://www.cytocoreinc.com/role/BankDebtsAndLinesOfCreditDetail Bank Debts and Lines of Credit (Detail) false false R39.htm 139 - Disclosure - Bank Debts and Lines of Credit (Detail1) Sheet http://www.cytocoreinc.com/role/BankDebtsAndLinesOfCreditDetail1 Bank Debts and Lines of Credit (Detail1) false false R40.htm 140 - Statement - Bank Debts and Lines of Credit - Additional Information (Detail) Sheet http://www.cytocoreinc.com/role/BankDebtsAndLinesOfCreditAdditionalInformationDetail Bank Debts and Lines of Credit - Additional Information (Detail) false false R41.htm 141 - Disclosure - Accrued Expenses (Detail) Sheet http://www.cytocoreinc.com/role/AccruedExpensesDetail Accrued Expenses (Detail) false false R42.htm 142 - Disclosure - Reconciliation of Numerator and Denominator Used in Calculation of Loss Per Share (Detail) Sheet http://www.cytocoreinc.com/role/ReconciliationOfNumeratorAndDenominatorUsedInCalculationOfLossPerShareDetail Reconciliation of Numerator and Denominator Used in Calculation of Loss Per Share (Detail) false false R43.htm 143 - Disclosure - Summary of Preferred Stock (Detail) Sheet http://www.cytocoreinc.com/role/SummaryOfPreferredStockDetail Summary of Preferred Stock (Detail) false false R44.htm 144 - Disclosure - Summary of Preferred Stock (Parenthetical) (Detail) Sheet http://www.cytocoreinc.com/role/SummaryOfPreferredStockParentheticalDetail Summary of Preferred Stock (Parenthetical) (Detail) false false R45.htm 145 - Disclosure - Summary of Preferred Stock Terms (Detail) Sheet http://www.cytocoreinc.com/role/SummaryOfPreferredStockTermsDetail Summary of Preferred Stock Terms (Detail) false false R46.htm 146 - Disclosure - Summary of Preferred Stock Terms (Parenthetical) (Detail) Sheet http://www.cytocoreinc.com/role/SummaryOfPreferredStockTermsParentheticalDetail Summary of Preferred Stock Terms (Parenthetical) (Detail) false false R47.htm 147 - Disclosure - Stockholders' Equity (Warrants And Options Issued Outside Of The Plan For Employee Compensation) (Detail) Sheet http://www.cytocoreinc.com/role/StockholdersEquityWarrantsAndOptionsIssuedOutsideOfPlanForEmployeeCompensationDetail Stockholders' Equity (Warrants And Options Issued Outside Of The Plan For Employee Compensation) (Detail) false false R48.htm 148 - Disclosure - Stockholders' Equity (Deficit) - Additional Information (Detail) Sheet http://www.cytocoreinc.com/role/StockholdersEquityDeficitAdditionalInformationDetail Stockholders' Equity (Deficit) - Additional Information (Detail) false false R49.htm 149 - Disclosure - Leases (Future Minimum Annual Lease Payments Under These Leases) (Detail) Sheet http://www.cytocoreinc.com/role/LeasesFutureMinimumAnnualLeasePaymentsUnderTheseLeasesDetail Leases (Future Minimum Annual Lease Payments Under These Leases) (Detail) false false R50.htm 150 - Disclosure - Leases-Additional Information (Detail) Sheet http://www.cytocoreinc.com/role/LeasesadditionalInformationDetail Leases-Additional Information (Detail) false false R51.htm 151 - Disclosure - Income Taxes (Provision For Federal Income Taxes) (Detail) Sheet http://www.cytocoreinc.com/role/IncomeTaxesProvisionForFederalIncomeTaxesDetail Income Taxes (Provision For Federal Income Taxes) (Detail) false false R52.htm 152 - Disclosure - Income Taxes (Provision For Deferred Income Taxes) (Detail) Sheet http://www.cytocoreinc.com/role/IncomeTaxesProvisionForDeferredIncomeTaxesDetail Income Taxes (Provision For Deferred Income Taxes) (Detail) false false R53.htm 153 - Disclosure - Income Taxes (Provision For Income Taxes Differs From The Expected Tax Provision) (Detail) Sheet http://www.cytocoreinc.com/role/IncomeTaxesProvisionForIncomeTaxesDiffersFromExpectedTaxProvisionDetail Income Taxes (Provision For Income Taxes Differs From The Expected Tax Provision) (Detail) false false R54.htm 154 - Disclosure - Income Taxes (Significant Components Of The Company's Deferred Tax Assets And Liabilities) (Detail) Sheet http://www.cytocoreinc.com/role/IncomeTaxesSignificantComponentsOfCompanysDeferredTaxAssetsAndLiabilitiesDetail Income Taxes (Significant Components Of The Company's Deferred Tax Assets And Liabilities) (Detail) false false R55.htm 155 - Disclosure - Income Taxes (Company's Gross Unrecognized Tax Benefits) (Detail) Sheet http://www.cytocoreinc.com/role/IncomeTaxesCompanysGrossUnrecognizedTaxBenefitsDetail Income Taxes (Company's Gross Unrecognized Tax Benefits) (Detail) false false R56.htm 156 - Disclosure - Income Taxes-Additional Information (Detail) Sheet http://www.cytocoreinc.com/role/IncomeTaxesadditionalInformationDetail Income Taxes-Additional Information (Detail) false false R57.htm 157 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.cytocoreinc.com/role/CommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) false false R58.htm 158 - Disclosure - Segment Information (Detail) Sheet http://www.cytocoreinc.com/role/SegmentInformationDetail Segment Information (Detail) false false R59.htm 159 - Statement - Subsequent Event - Additional Information (Detail) Sheet http://www.cytocoreinc.com/role/SubsequentEventAdditionalInformationDetail Subsequent Event - Additional Information (Detail) false false All Reports Book All Reports Element mdit_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsApplicationValuationAllowance had a mix of decimals attribute values: 0 2. Element mdit_StockConversionPricePerShare had a mix of decimals attribute values: 0 2. Element us-gaap_DebtInstrumentFaceAmount had a mix of decimals attribute values: -5 0. Element us-gaap_DeferredTaxAssetsNet had a mix of decimals attribute values: -3 0. Element us-gaap_DueToRelatedPartiesCurrent had a mix of decimals attribute values: -3 0. Element us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance had a mix of decimals attribute values: 0 3. Element us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential had a mix of decimals attribute values: 0 1. Element us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity had a mix of decimals attribute values: -5 0. Element us-gaap_LinesOfCreditCurrent had a mix of decimals attribute values: -3 0. Element us-gaap_PreferredStockLiquidationPreferenceValue had a mix of decimals attribute values: -3 0. Element us-gaap_ProceedsFromIssuanceOfPrivatePlacement had a mix of decimals attribute values: -5 -3. Element us-gaap_RepaymentsOfRelatedPartyDebt had a mix of decimals attribute values: -3 0. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice had a mix of decimals attribute values: 0 2. Element us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice had a mix of decimals attribute values: 0 2. Element us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice had a mix of decimals attribute values: 0 2. 'Monetary' elements on report '156 - Disclosure - Income Taxes-Additional Information (Detail)' had a mix of different decimal attribute values. 'Monetary' elements on report '159 - Statement - Subsequent Event - Additional Information (Detail)' had a mix of different decimal attribute values. Process Flow-Through: 102 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: 103 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME Process Flow-Through: 105 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Parenthetical) Process Flow-Through: 106 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Process Flow-Through: 115 - Statement - Stockholders' Equity Process Flow-Through: 121 - Statement - Summary of Significant Accounting Policies (Policies) Process Flow-Through: 122 - Statement - Summary of Significant Accounting Policies (Tables) Process Flow-Through: 126 - Statement - Bank Debts and Line of Credit (Tables) Process Flow-Through: 130 - Statement - Income Taxes (Tables) Process Flow-Through: 132 - Statement - The Company and Basis of Presentation - Additional Information (Detail) Process Flow-Through: Removing column 'Dec. 31, 2014' Process Flow-Through: Removing column 'Dec. 31, 2013' Process Flow-Through: 133 - Statement - Summary of Significant Accounting Policies (Detail) Process Flow-Through: 140 - Statement - Bank Debts and Lines of Credit - Additional Information (Detail) Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2014 USD ($)' Process Flow-Through: Removing column 'Dec. 31, 2013 USD ($)' Process Flow-Through: Removing column '1 Months Ended Feb. 23, 2015 Subsequent Event [Member] USD ($)' Process Flow-Through: 159 - Statement - Subsequent Event - Additional Information (Detail) Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2014' mdit-20141231.xml mdit-20141231.xsd mdit-20141231_cal.xml mdit-20141231_def.xml mdit-20141231_lab.xml mdit-20141231_pre.xml true true